Filter
629
Filtered Results: 629
Text search:
Mild
COVID
Featured
Recommendations
108
New Publications
2
Language
Document type
Guidelines
251
Studies & Reports
130
Fact sheets
86
Manuals
51
Strategic & Response Plan
38
Situation Updates
22
Training Material
15
Infographics
10
Brochures
7
Resource Platforms
6
No document type
6
Videos
4
Online Courses
3
Countries / Regions
Global
31
India
28
South Africa
25
Germany
24
Syria
22
Latin America and the Carribbean
22
Western and Central Europe
22
Brazil
20
Middle East and North Africa
18
Russia
18
Africa
15
West and Central Africa
15
East and Southern Africa
15
Eastern Europe and Central Asia
14
Kenya
11
South–East Asia Region
10
Yemen
9
South Sudan
9
Mozambique
6
Bangladesh
6
Nigeria
5
Western Pacific Region
5
Vietnam
5
Angola
5
Malawi
4
Jordan
4
United Kingdom
4
Eastern Europe
4
Tajikistan
3
Ukraine
3
Ghana
3
China
3
Chile
3
Philippines
3
Guinea-Bissau
3
Paraguay
3
Lebanon
3
Palestine
3
Ethiopia
3
Nepal
2
Colombia
2
Turkey
2
Kazakhstan
2
Laos
2
Burkina Faso
2
Afghanistan
2
Zimbabwe
2
Cambodia
2
Congo, Democratic Republic of
2
Portugal
2
Côte d’Ivoire / Ivory Coast
2
Iraq
2
Ecuador
2
Pakistan
2
North Macedonia
1
Switzerland
1
Thailand
1
Serbia
1
Australia
1
Benin
1
Rwanda
1
Fiji
1
Singapore
1
Kyrgyzstan
1
Congo-Brazzaville
1
Uzbekistan
1
Peru
1
Austria
1
Armenia
1
Asia
1
Venezuela
1
Saudi Arabia
1
North America
1
France
1
Spain
1
South Korea
1
Bolivia
1
Argentina
1
Uganda
1
Moldova
1
Sri Lanka
1
Egypt
1
Sudan
1
Georgia
1
Mali
1
Chad
1
Somalia
1
Liberia
1
Myanmar / Burma
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
269
Clinical Guidelines
34
Public Health
27
Women & Child Health
19
Key Resources
13
Capacity Building
9
Pharmacy & Technologies
5
Toolboxes
COVID-19
464
NCDs
21
Rapid Response
13
Mental Health
12
Refugee
11
Planetary Health
11
Conflict
10
TB
8
Caregiver
8
HIV
7
Disability
6
NTDs
6
Pharmacy
5
AMR
5
Natural Hazards
3
Health Financing Toolbox
3
Cholera
1
Ebola
1
Zika
1
Risk Communication and Community Engagement messages
Coronavirus disease 2019 has a mild disease course in children and adolescents. Chronic respiratory conditions, including asthma, have been suggested as risk factors; however, asthma in children is highly variable in both triggers and severity.
During the pandemic, pediatric asthma services limite...
For COVID-19, as for many infectious diseases, the true level of transmission is frequently underestimated because a substantial proportion of people with the infection are undetected either because they are asymptomatic or have only mild symptoms and thus typically fail to present at healthcare fac...
Published 24 January 2021
The term “Long COVID-19” covers a wide spectrum of symptoms that can occur or persist weeks and even months after an acute infection, not only after severe but also after initially mild courses. Primary symptoms are exhaustion and fatigue, but also dyspnea on exertion,...
SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, resulting in fewer identified cases of COVID-19 in ch...
This document provides guidance on infection prevention and control (IPC) measures for people with suspected or confirmed coronavirus disease (COVID-19) who are experiencing mild symptoms that do not require hospitalisation, therefore self-isolating at home.
Vaccines are designed to give you immunity without the dangers of getting the disease. It’s common to experience some mild to moderate side effects when receiving vaccinations. This is because your immune system instructs your body to increase blood flow so more immune cells can circulate, and it ...
SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, resulting in fewer identified cases of COVID-19 in ch...
SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, resulting in fewer identified cases of COVID-19 in ch...
Coronavirus disease 2019 is also known as COVID-19. It is a viral illness that infects the lungs. It is caused by a virus called SARS-associated coronavirus (SARS-CoV-2). This illness was first seen in late 2019 in China and has spread across the world.
The signs of COVID-19 are like the flu, and y...
The Clinical Management of Patients with COVID-19 course series is developed for healthcare workers during the COVID-19 pandemic. The course provides crucial knowledge necessary to provide safe, effective quality patient care. Presentations address all aspects of clinical management, including facil...
Этот документ представляет собой обновление
рекомендаций «Уход на дому за пациентами с легкой
формой заболевания COVID‑19 и тактика ведения
контактных лиц», опубл...
Ivermectin is an antiparasitic drug approved for the treatment of parasitic infections, including strongyloidiasis and onchocerciasis in humans. There is a reported increase in the use of ivermectin for the prevention and treatment of COVID-19 by the public in African Union Member States.
Currently...
Covid-19 Test to Treat Guidelines
recommended
n response to the outbreak, the Africa Centres for Disease Control and Prevention (Africa CDC) has been supporting African Union Member States in responding to the COVID-19 pandemic through a variety of interventions such as non-pharmaceutical interventions, quarantine, testing, isolation, contact t...
31 March 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
COVID-19 vaccines are safe, and getting v...
Coronavirus disease 2019 (COVID-19) is an acute infectious respiratory disease caused by a newly discovered coronavirus (SARS-CoV-2).
Most people infected with the COVID-19 virus experience mild to moderate respiratory illness and recover without requiring special treatment, the disease presentati...
It is intended for use among clinicians taking care of moderate to severe COVID-19 cases.
The COVID-19 outbreak has brought with it the need for improved critical care for patients who develop severe disease. The majority of COVID-19 patients present with mild to moderate illness, 15% develop sever...
Wearing a face mask can help reduce the spread of COVID-19 in the community by reducing the release of respiratory droplets from asymptomatic / pre-symptomatic individuals or those with mild non-specific symptoms. The use of face masks for this purpose may be adopted to reduce the societal impact as...
